These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 2426252

  • 1. The ninth component of human complement (C9). Functional activity of the b fragment.
    Shiver JW, Dankert JR, Donovan JJ, Esser AF.
    J Biol Chem; 1986 Jul 25; 261(21):9629-36. PubMed ID: 2426252
    [Abstract] [Full Text] [Related]

  • 2. Isolation of the C9b fragment of human complement component C9 using urea in the absence of detergents.
    Gu X, Dankert JR.
    J Immunol Methods; 1996 Jan 16; 189(1):37-45. PubMed ID: 8576578
    [Abstract] [Full Text] [Related]

  • 3. An amphiphilic structure of the ninth component of human complement. Evidence from analysis of fragments produced by alpha-thrombin.
    Biesecker G, Gerard C, Hugli TE.
    J Biol Chem; 1982 Mar 10; 257(5):2584-90. PubMed ID: 6460761
    [Abstract] [Full Text] [Related]

  • 4. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9.
    Yoden A, Moriyama T, Inoue K, Inai S.
    J Immunol; 1988 Apr 01; 140(7):2317-21. PubMed ID: 3351301
    [Abstract] [Full Text] [Related]

  • 5. Photolabeling of a hydrophobic domain of the ninth component of human complement.
    Ishida B, Wisnieski BJ, Lavine CH, Esser AF.
    J Biol Chem; 1982 Sep 25; 257(18):10551-3. PubMed ID: 7107623
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The architecture of complement component C9 and poly(C9).
    DiScipio RG, Hugli TE.
    J Biol Chem; 1985 Nov 25; 260(27):14802-9. PubMed ID: 4055801
    [Abstract] [Full Text] [Related]

  • 8. Analysis of C5b-8 binding sites in the C9 molecule using monoclonal antibodies: participation of two separate epitopes of C9 in C5b-8 binding.
    Hatanaka M, Seya T, Yoden A, Fukamoto K, Semba T, Inai S.
    Mol Immunol; 1992 Nov 25; 29(7-8):911-6. PubMed ID: 1378934
    [Abstract] [Full Text] [Related]

  • 9. Localization and molecular modelling of the membrane-inserted domain of the ninth component of human complement and perforin.
    Peitsch MC, Amiguet P, Guy R, Brunner J, Maizel JV, Tschopp J.
    Mol Immunol; 1990 Jul 25; 27(7):589-602. PubMed ID: 2395434
    [Abstract] [Full Text] [Related]

  • 10. Formation of ion-conducting channels by the membrane attack complex proteins of complement.
    Shiver JW, Dankert JR, Esser AF.
    Biophys J; 1991 Oct 25; 60(4):761-9. PubMed ID: 1720679
    [Abstract] [Full Text] [Related]

  • 11. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J, Chonn A, Hertig S, French LE.
    J Immunol; 1993 Aug 15; 151(4):2159-65. PubMed ID: 8345200
    [Abstract] [Full Text] [Related]

  • 12. Identity of a peptide domain of human C9 that is bound by the cell-surface complement inhibitor, CD59.
    Chang CP, Hüsler T, Zhao J, Wiedmer T, Sims PJ.
    J Biol Chem; 1994 Oct 21; 269(42):26424-30. PubMed ID: 7523406
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the macroscopic and single channel conductance properties of colicin E1 and its COOH-terminal tryptic peptide.
    Bullock JO, Cohen FS, Dankert JR, Cramer WA.
    J Biol Chem; 1983 Aug 25; 258(16):9908-12. PubMed ID: 6309789
    [Abstract] [Full Text] [Related]

  • 14. Comparison of channels formed by poly C9, C5b-8 and the membrane attack complex of complement.
    Zalman LS, Müller-Eberhard HJ.
    Mol Immunol; 1990 Jun 25; 27(6):533-7. PubMed ID: 1696352
    [Abstract] [Full Text] [Related]

  • 15. Molecular composition of the terminal membrane and fluid-phase C5b-9 complexes of rabbit complement. Absence of disulphide-bonded C9 dimers in the membrane complex.
    Bhakdi S, Tranum-Jensen J.
    Biochem J; 1983 Mar 01; 209(3):753-61. PubMed ID: 6870789
    [Abstract] [Full Text] [Related]

  • 16. Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.
    Zalman LS, Wood LM, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1986 Sep 01; 83(18):6975-9. PubMed ID: 2428045
    [Abstract] [Full Text] [Related]

  • 17. Several epitopes on native human complement C9 are involved in interaction with the C5b-8 complex and other C9 molecules.
    Kontermann R, Deppisch R, Rauterberg EW.
    Eur J Immunol; 1990 Mar 01; 20(3):623-8. PubMed ID: 1690659
    [Abstract] [Full Text] [Related]

  • 18. Fluid-phase assembly of the membrane attack complex of complement.
    Silversmith RE, Nelsestuen GL.
    Biochemistry; 1986 Feb 25; 25(4):841-51. PubMed ID: 3964648
    [Abstract] [Full Text] [Related]

  • 19. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW, Shin ML.
    J Immunol; 1984 Oct 25; 133(4):2133-7. PubMed ID: 6470486
    [Abstract] [Full Text] [Related]

  • 20. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1984 Sep 25; 133(3):1453-63. PubMed ID: 6747293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.